China Medical Tourism Statistics 2025-2026
Comprehensive, cited data on international patient volumes, treatment costs, hospital quality metrics, and market trends for medical tourism in China. Data sourced from the National Health Commission, Fudan University, and JCI.
Last updated: August 2026 · Sources cited below each section
Key Statistics at a Glance
The most-cited data points about medical tourism in China.
International Patient Volume
China has seen rapid growth in international patient visits over the past decade, with a significant rebound post-pandemic. The National Health Commission tracks these figures annually.
Source: National Health Commission of China (NHC), annual reports
| Year | International Visits | Growth | Notes |
|---|---|---|---|
| 2019 | ~730,000 | Baseline | Pre-pandemic peak |
| 2020 | ~140,000 | -81% | COVID-19 border closures |
| 2021 | ~180,000 | +29% | Partial recovery |
| 2022 | ~320,000 | +78% | Border reopening began |
| 2023 | ~680,000 | +113% | Full reopening + visa-free expansion |
| 2024 | ~1,050,000 | +54% | Rapid recovery continues |
| 2025 | 1,280,000 | +22% | New record; NHC official data |
Treatment Cost Comparison: China vs World
China offers substantial cost advantages for major medical procedures. The table below shows average price ranges for common treatments sought by international patients.
Sources: Hospital international departments, published pricing data (2025-2026). Prices are estimates and may vary by hospital and case complexity.
| Treatment | China (USD) | USA (USD) | UK (USD) | Thailand (USD) | Savings vs US |
|---|---|---|---|---|---|
| CAR-T Cell Therapy | $40,000-$80,000 | $400,000+ | $350,000+ | N/A | 80-90% |
| Proton Therapy | $30,000-$55,000 | $100,000-$200,000 | $80,000-$150,000 | N/A | 70-80% |
| Knee Replacement | $8,000-$15,000 | $30,000-$70,000 | $25,000-$40,000 | $12,000-$18,000 | 70-85% |
| Heart Bypass (CABG) | $10,000-$20,000 | $70,000-$200,000 | $40,000-$60,000 | $15,000-$22,000 | 70-90% |
| Hip Replacement | $7,000-$14,000 | $30,000-$60,000 | $20,000-$35,000 | $10,000-$17,000 | 70-85% |
| Liver Transplant | $50,000-$80,000 | $300,000-$500,000 | $150,000-$250,000 | $60,000-$100,000 | 75-85% |
| Spinal Fusion | $8,000-$18,000 | $50,000-$110,000 | $30,000-$50,000 | $12,000-$20,000 | 70-85% |
| Full Body Check-up | $500-$2,000 | $3,000-$10,000 | $2,000-$5,000 | $500-$1,500 | 70-85% |
| IVF (per cycle) | $4,000-$8,000 | $12,000-$25,000 | $8,000-$15,000 | $5,000-$8,000 | 60-70% |
| Dental Implant | $800-$2,000 | $3,000-$6,000 | $2,000-$4,000 | $1,200-$2,500 | 60-70% |
Advanced Therapies in China
China has become a global leader in several cutting-edge medical therapies, attracting international patients seeking treatments unavailable or prohibitively expensive elsewhere.
CAR-T Cell Therapy
- •6 NMPA-approved products: Yescarta, Relma-cel, Fucaso, Carteyva, Yikaida, Carvykti
- •Cost: $40,000-$80,000 vs $400,000+ in the US
- •China has the highest number of CAR-T clinical trials globally (300+ active trials as of 2025)
- •Leading centers: Peking University Cancer Hospital, Chinese PLA General Hospital, West China Hospital
Proton & Heavy Ion Therapy
- •Cost: $30,000-$55,000 vs $100,000-$200,000 in the US
- •Shanghai Proton & Heavy Ion Center — one of the world's most advanced facilities
- •10+ proton therapy centers operational in China (2026)
- •China leads globally in carbon ion therapy with multiple heavy ion facilities
Cancer Treatment
- •Top 3 cancer hospitals: Sun Yat-sen University Cancer Center, Fudan University Cancer Center, Cancer Hospital CAMS (Beijing)
- •China handles 4.5M+ new cancer cases annually, driving high case volumes and expertise
- •Immunotherapy options including PD-1/PD-L1 inhibitors available at lower costs than Western markets
Traditional Chinese Medicine (TCM)
- •Integrative oncology combining TCM with Western medicine is uniquely available in China
- •Leading TCM hospitals: Guangzhou University of Chinese Medicine, Beijing University of Chinese Medicine
- •Growing international demand for TCM rehabilitation and chronic disease management
Hospital Quality & Accreditation
China's hospital grading system and international accreditations provide structured quality assurance for international patients.
Sources: JCI directory, Fudan Hospital Ranking, national health ministry reports. Numbers are approximate.
| Quality Metric | China | Thailand | India | South Korea |
|---|---|---|---|---|
| JCI-Accredited Hospitals | 30+ | 60+ | 40+ | 30+ |
| National Hospital Ranking System | Fudan (6,000 peers) | HA (Thai Ministry) | NABH | HIRA |
| Top Hospital Grade System | Grade 3A (三甲) | HA Accreditation | NABH/NABL | Tertiary Hospitals |
| International Patient Volume (2025) | 1.28M | ~2.5M | ~1.0M | ~0.6M |
| Avg. Doctor:Patient Ratio (top hospitals) | 1:4 | 1:5 | 1:6 | 1:3 |
Top-Ranked Hospitals (Fudan 2025)
Source: Fudan University Hospital Management Research Institute, 2025 Comprehensive Ranking
| Rank | Hospital | City | Key Strengths | JCI |
|---|---|---|---|---|
| #1 | Peking Union Medical College Hospital (PUMCH) | Beijing | Overall #1, Rare diseases, Internal medicine | ✓ |
| #2 | West China Hospital, Sichuan University | Chengdu | Largest hospital globally (4,300 beds), Research | ✓ |
| #3 | Chinese PLA General Hospital (301 Hospital) | Beijing | Oncology, Cardiology, Transplant | — |
| #4 | Ruijin Hospital, Shanghai Jiao Tong University | Shanghai | Endocrinology, Hematology | ✓ |
| #5 | Zhongshan Hospital, Fudan University | Shanghai | Cardiology, Liver surgery, Hepatobiliary | ✓ |
| #6 | Huashan Hospital, Fudan University | Shanghai | Neurosurgery #1, Dermatology, Infectious diseases | — |
| #7 | Tongji Hospital, Tongji Medical College | Wuhan | Obstetrics & Gynecology, Rehabilitation | — |
Visa & Travel Data
Source: China Ministry of Foreign Affairs (2026). Visa policies change frequently; verify before travel.
| Region | Visa-Free Countries | Stay Duration | Key Nationalities |
|---|---|---|---|
| Europe | 30+ countries | 30 days | France, Germany, Italy, Netherlands, Spain, Switzerland |
| Asia-Pacific | 15+ countries | 15-30 days | Singapore, Malaysia, Thailand, Australia, New Zealand |
| Americas | Limited | Varies | Brazil (visa-free); US/Canada require visa |
| Middle East | Growing | 30 days | UAE, Qatar, Saudi Arabia (recent expansions) |
| Africa | Select | 30 days | South Africa, Mauritius, Seychelles |
Market Trends & Projections
Projections based on current growth trends and government policy targets. Sources: NHC, industry reports, Medora analysis.
| Metric | 2023 | 2025 | 2030 (Projected) |
|---|---|---|---|
| International Patient Visits | ~680K | 1.28M | ~3.0M |
| Market Revenue (est.) | $6-8B | $12-15B | $30-40B |
| CAR-T Products Available | 4 | 6 | 10+ |
| Proton Therapy Centers | 6 | 10+ | 20+ |
| JCI-Accredited Hospitals | ~25 | 30+ | 50+ |
| Visa-Free Countries | ~30 | 50+ | 70+ |
Frequently Asked Questions
How many international patients visit China for medical treatment?
China recorded approximately 1.28 million international patient visits in 2025, according to the National Health Commission (NHC). This represents a significant increase from previous years, driven by China's advanced medical technology, competitive pricing, and expanding visa-free policies for over 50 countries.
How much cheaper is medical treatment in China compared to the US?
Medical treatments in China cost 50-90% less than in the United States. For example, CAR-T cell therapy costs $40,000-$80,000 in China vs $400,000+ in the US (90% savings). Proton therapy costs $30,000-$55,000 vs $100,000-$200,000 (70-80% savings). Knee replacement surgery costs $8,000-$15,000 vs $30,000-$70,000 (70-85% savings).
What is the size of China's medical tourism market?
China's medical tourism market was valued at approximately $12-15 billion in 2025 and is projected to grow at a CAGR of 15-20% through 2030. Key growth drivers include advanced therapies (CAR-T, proton therapy), government support for medical tourism zones, and expanding international hospital accreditation.
Which are the top medical tourism treatments in China?
The most sought-after treatments by international patients in China include: CAR-T cell therapy (6 NMPA-approved products), proton and heavy ion therapy, cancer surgery and immunotherapy, organ transplantation, orthopedic surgery, cardiac surgery, traditional Chinese medicine (TCM) integrative treatment, and comprehensive health check-ups.
How many JCI-accredited hospitals are in China?
As of 2026, over 30 hospitals in mainland China hold JCI (Joint Commission International) accreditation, concentrated primarily in Beijing, Shanghai, and Guangzhou. JCI accreditation verifies that a hospital meets over 1,100 international healthcare quality standards.
What visa do I need for medical tourism in China?
Over 50 countries are eligible for visa-free entry to China (30-day stays). For treatment exceeding 30 days, patients need an S2 visa (short-term private visit), which costs $140-$185 and takes 4-7 business days to process. Some hospitals can issue invitation letters to facilitate visa applications.
Data Sources & Citations
- National Health Commission of China (NHC) — International patient visit statistics, healthcare infrastructure data
- Fudan University Hospital Management Research Institute — Hospital ranking data, peer evaluation methodology (~6,000 evaluators)
- Joint Commission International (JCI) — Accreditation status and standards (1,100+ evaluation criteria)
- National Medical Products Administration (NMPA) — CAR-T and drug approval data
- China Ministry of Foreign Affairs — Visa policy and bilateral agreement data
- Hospital international departments — Treatment cost ranges (published 2025-2026)
Disclaimer: All statistics are provided for informational purposes and may vary by source. Prices are estimates and depend on individual medical conditions, hospital selection, and treatment complexity. Always verify current data with official sources before making medical travel decisions.
Need a Personalized Hospital Recommendation?
Our free assessment matches you with the best hospitals based on Fudan Ranking data and your specific medical needs.